Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
X

XENE

Nasdaq

Xenon Pharmaceuticals Inc.

Latest disclosureOctober 1, 2026
Insider score Why 89?
89/ 100
Qualifying buys · 30d
$1.68M

2 purchases · 5 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 41

Limited filing history
All41Buying2Selling5Other34
Filters

Last 30 daysInsiders bought $1.68M · 2 buyers, led by Ian Mortimer (CEO) with $1.12M. No qualifying insider sales.

34 of 41 trades · May 12, 2026 – September 30, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.

Showing the first 6 of 20 trades on this page.

Exercise or conversion

Dawn Svoronos

Director

Common Shares

Value context
$41.92K
Reported price
$8.15 / share
Traded September 1, 2026Filed September 3, 2026SEC filing
Exercise or conversion

Dawn Svoronos

Director

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$8.15 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 1, 2026Filed September 3, 2026SEC filing
Exercise or conversion

Gary Patou

Director

Common Shares

Value context
Unavailable
Reported price
Price not reported
Traded June 1, 2026Filed June 3, 2026SEC filing
Exercise or conversion

Gary Patou

Director

Restricted Share Units

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded June 1, 2026Filed June 3, 2026SEC filing
Award disclosed

Gary Patou

Director

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 3, 2026Filed June 3, 2026SEC filing
Award disclosed

Gary Patou

Director

Restricted Share Units

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 3, 2026Filed June 3, 2026SEC filing
Exercise or conversion

Patrick Machado

Director

Common Shares

Value context
Unavailable
Reported price
Price not reported
Traded June 1, 2026Filed June 3, 2026SEC filing
Exercise or conversion

Patrick Machado

Director

Restricted Share Units

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded June 1, 2026Filed June 3, 2026SEC filing
Award disclosed

Patrick Machado

Director

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 3, 2026Filed June 3, 2026SEC filing
Award disclosed

Patrick Machado

Director

Restricted Share Units

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 3, 2026Filed June 3, 2026SEC filing
Exercise or conversion

Justin D. Gover

Director

Common Shares

Value context
Unavailable
Reported price
Price not reported
Traded June 1, 2026Filed June 3, 2026SEC filing
Exercise or conversion

Justin D. Gover

Director

Restricted Share Units

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded June 1, 2026Filed June 3, 2026SEC filing
Award disclosed

Justin D. Gover

Director

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 3, 2026Filed June 3, 2026SEC filing
Award disclosed

Justin D. Gover

Director

Restricted Share Units

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 3, 2026Filed June 3, 2026SEC filing
Exercise or conversion

Elizabeth A. Garofalo

Director

Common Shares

Value context
Unavailable
Reported price
Price not reported
Traded June 1, 2026Filed June 3, 2026SEC filing
Exercise or conversion

Elizabeth A. Garofalo

Director

Restricted Share Units

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded June 1, 2026Filed June 3, 2026SEC filing
Award disclosed

Elizabeth A. Garofalo

Director

Share Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 3, 2026Filed June 3, 2026SEC filing
Award disclosed

Elizabeth A. Garofalo

Director

Restricted Share Units

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 3, 2026Filed June 3, 2026SEC filing
Exercise or conversion

Steven Gannon

Director

Common Shares

Value context
Unavailable
Reported price
Price not reported
Traded June 1, 2026Filed June 3, 2026SEC filing
Tax or exercise withholding

Steven Gannon

Director

Common Shares

Value context
$75.63K
Reported price
$53.41 / share
Traded June 1, 2026Filed June 3, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
DirectorCommon SharesOption exercise or conversion5,144$8.15 / share$41.92KSep 1Filed Sep 3 · 2d laterSEC filing
DirectorStock Option (Right to Buy)Option exercise or conversionDerivative units5,144$8.15 exercise / conversion priceNot a separate purchaseSep 1Filed Sep 3 · 2d laterSEC filing
DirectorCommon SharesOption exercise or conversion2,645Price not reportedUnavailableJun 1Filed Jun 3 · 2d laterSEC filing
DirectorRestricted Share UnitsOption exercise or conversionDerivative units2,645Exercise / conversion price not reportedNot a separate purchaseJun 1Filed Jun 3 · 2d laterSEC filing
DirectorShare Option (Right to Buy)Grant or awardDerivative units10,507Award · no purchase priceNon-cash awardJun 3Filed Jun 3 · 0d laterSEC filing
DirectorRestricted Share UnitsGrant or awardDerivative units1,593Award · no purchase priceNon-cash awardJun 3Filed Jun 3 · 0d laterSEC filing
DirectorCommon SharesOption exercise or conversion2,645Price not reportedUnavailableJun 1Filed Jun 3 · 2d laterSEC filing
DirectorRestricted Share UnitsOption exercise or conversionDerivative units2,645Exercise / conversion price not reportedNot a separate purchaseJun 1Filed Jun 3 · 2d laterSEC filing
DirectorShare Option (Right to Buy)Grant or awardDerivative units10,507Award · no purchase priceNon-cash awardJun 3Filed Jun 3 · 0d laterSEC filing
DirectorRestricted Share UnitsGrant or awardDerivative units1,593Award · no purchase priceNon-cash awardJun 3Filed Jun 3 · 0d laterSEC filing
DirectorCommon SharesOption exercise or conversion2,645Price not reportedUnavailableJun 1Filed Jun 3 · 2d laterSEC filing
DirectorRestricted Share UnitsOption exercise or conversionDerivative units2,645Exercise / conversion price not reportedNot a separate purchaseJun 1Filed Jun 3 · 2d laterSEC filing
DirectorShare Option (Right to Buy)Grant or awardDerivative units10,507Award · no purchase priceNon-cash awardJun 3Filed Jun 3 · 0d laterSEC filing
DirectorRestricted Share UnitsGrant or awardDerivative units1,593Award · no purchase priceNon-cash awardJun 3Filed Jun 3 · 0d laterSEC filing
DirectorCommon SharesOption exercise or conversion2,645Price not reportedUnavailableJun 1Filed Jun 3 · 2d laterSEC filing
DirectorRestricted Share UnitsOption exercise or conversionDerivative units2,645Exercise / conversion price not reportedNot a separate purchaseJun 1Filed Jun 3 · 2d laterSEC filing
DirectorShare Option (Right to Buy)Grant or awardDerivative units10,507Award · no purchase priceNon-cash awardJun 3Filed Jun 3 · 0d laterSEC filing
DirectorRestricted Share UnitsGrant or awardDerivative units1,593Award · no purchase priceNon-cash awardJun 3Filed Jun 3 · 0d laterSEC filing
DirectorCommon SharesOption exercise or conversion2,645Price not reportedUnavailableJun 1Filed Jun 3 · 2d laterSEC filing
DirectorCommon SharesExercise-price or tax withholding1,416$53.41 / share$75.63KJun 1Filed Jun 3 · 2d laterSEC filing

Showing the latest 20 of 34 trades. Show all 34 trades

Congress transactions 0

All Congress filings
No disclosed congressional trades for XENE in the imported filings.

This reflects the filings imported so far, not a complete trading history.

Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

Qualifying common-equity purchase value

$1,681,140 of common-equity purchase value after transaction-age decay across 180 days.

+25 pts

Distinct buying groups

2 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.

+14 pts

CEO purchase

Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.

+15 pts

CFO purchase

Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.

+10 pts

Insider buying cluster

2 buying groups inside 30 transaction-date days, public by the snapshot cutoff.

+15 pts

Material reported holdings increase

At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.

+10 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage
Source
SEC EDGAR · Form 4
Issuer CIK
0001582313
Latest public acceptance
Oct 1, 2026, 01:20 PM UTC
Score calculated
Oct 7, 2026, 12:09 AM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.